AI shows considerable potential for medical diagnosis through imaging data, though it often struggles with rare diseases due ...

Relief Therapeutics Holding SA / Key word (s): Study results Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents 25-Oct-2024 / 07:00 CET/CEST Release of an ad hoc ...

Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment ...

Scientist Michel Brahic's new book delves into the world of prions, the culprits behind some of the scariest illnesses around ...

The state-of-the-art facility is equipped to handle up to ... differences between people living with long COVID and long Lyme disease/Lyme+, ME/CFS, EDS, and other infection-associated complex ...

Add articles to your saved list and come back to them any time. Milan: Sammy Basso, who was the longest-living survivor of the rare genetic disease progeria, has died at the age of 28, the Italian ...

The Pullman laboratory is paying attention to other diseases, too. WADDL recently diagnosed a rare case of plague in an Idaho deer. They are on the lookout for African swine fever, which is ...

An estimated one in 41 Shetlanders are carriers of the condition. Islanders are often susceptible to rare diseases because of a lack of genetic diversity in small insular populations. But ...

Recordati is floating $825 million upfront—plus another $250 million in potential commercial milestones—to get its hands on the global rights to Sanofi’s rare disease biologic Enjaymo.